Actualités Flex Pharma, Inc. - FLKS | Actions NASDAQ

Outils de qualité professionnelle, pour des investisseurs individuels.

Annual Report (10-k)

UNITED STATES SECURITIES AND EXCHANGE...

Current Report Filing (8-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ...

Flex Pharma Reports Fourth Quarter and Fiscal 2018 Financial Results

Flex Pharma, Inc. (NASDAQ: FLKS), today announced its financial results for the three months and fiscal year ended December 31, 2018...

Current Report Filing (8-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ...

Securities Registration: Business Combination (s-4)

Table of Contents As filed with the Securities and Exchange Commission on February 13...

Statement of Ownership (sc 13g)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities...

Annual Statement of Changes in Beneficial Ownership (5)

FORM 5 [ X ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may...

Statement of Beneficial Ownership (sc 13d)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange...

Statement of Changes in Beneficial Ownership (4)

FORM 4 [ X ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may...

Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may...

Current Report Filing (8-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C...

Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C...

Flex Pharma & Salarius Pharmaceuticals Announce Merger Agreement to Accelerate Clinical Development of Novel Epigenetic Thera...

– Lead Candidate in Clinical Trial for Treating Ewing Sarcoma – – Salarius Completes $6.4 Million Private Placement – – Conference...

Statement of Beneficial Ownership (sc 13d)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act...

Initial Statement of Beneficial Ownership (3)

FORM 3 UNITED STATES SECURITIES AND EXCHANGE...

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Flex Pharma, Inc. (FLKS)

Outils de qualité professionnelle, pour des investisseurs individuels.

FLKS Actualités

Annual Report (10-k)

Current Report Filing (8-k)

Flex Pharma Reports Fourth Quarter and Fiscal 2018 Financial Results

Current Report Filing (8-k)

Securities Registration: Business Combination (s-4)

Statement of Ownership (sc 13g)

Annual Statement of Changes in Beneficial Ownership (5)

Statement of Beneficial Ownership (sc 13d)

Statement of Changes in Beneficial Ownership (4)

Statement of Changes in Beneficial Ownership (4)

Current Report Filing (8-k)

Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)

Flex Pharma & Salarius Pharmaceuticals Announce Merger Agreement to Accelerate Clinical Development of Novel Epigenetic Thera...

Statement of Beneficial Ownership (sc 13d)

Initial Statement of Beneficial Ownership (3)

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Flex Pharma, Inc. (FLKS) Actualités

Flex Pharma, Inc. (FLKS)

Outils de qualité professionnelle, pour des investisseurs individuels.

FLKS Actualités

Annual Report (10-k)

Current Report Filing (8-k)

Flex Pharma Reports Fourth Quarter and Fiscal 2018 Financial Results

Current Report Filing (8-k)

Securities Registration: Business Combination (s-4)

Statement of Ownership (sc 13g)

Annual Statement of Changes in Beneficial Ownership (5)

Statement of Beneficial Ownership (sc 13d)

Statement of Changes in Beneficial Ownership (4)

Statement of Changes in Beneficial Ownership (4)

Current Report Filing (8-k)

Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)

Flex Pharma & Salarius Pharmaceuticals Announce Merger Agreement to Accelerate Clinical Development of Novel Epigenetic Thera...

Statement of Beneficial Ownership (sc 13d)

Initial Statement of Beneficial Ownership (3)

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités